EYE: Nova Eye Medical Limited - Summary | Jitta

Nova Eye Medical Limited

AUS:EYE

Price
AU$0.12
Loss Chance
50.8%
3.26JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
22 / 126
305 / 1,069
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (54)
Recent Business Performance (64)
Financial Strength (32)
Return to Shareholders (0)
Competitive Advantage (55)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
3.26
100.00%
2.66
154.92%
Health Care Equipment
4.82
568.56%
6.55
35.22%
3.30
100.00%
COMPANY DESCRIPTION
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.